Immunocytochemical localisation of neuropeptide-containing nerve fibres in human labial glands.
Different neuropeptide-containing nerve fibers (vasoactive intestinal polypeptide, substance P, neuropeptide Y) and nitric oxide synthase (NOS) positive nerve fibers were investigated to clarify their role in the function of human labial glands using immunohisto- and immunocytochemical techniques. The distribution pattern of all immunoreactive nerve fibers was similar both in the control and in the Sjögren's syndrome specimens. A large number of thin varicose vasoactive intestinal polypeptide and NOS positive nerve fibers were seen around or in close contact with the acini. Some of the immunoreactive nerve fibers were associated with the salivary ducts and blood vessels. Substance P and neuropeptide Y immunoreactive nerve fibers were located mainly around the blood vessels. Immunocytochemistry demonstrated that some of the positive nerve fibers were in direct contact with the acini, blood vessels and with the lymphocytes. The gap between the membranes of immunoreactive nerve terminals and the target cells was 40 to 200 nm. The number of the nerve terminals in Sjögren's syndrome specimens was decreased and some degenerated axons were also found. These results suggest that these neuropeptides and nitric oxide might act as a neurotransmitter in the regulation of secretion and blood flow in the labial glands. These fibers might also alter the neuroimmunological processes, because the investigated neuropeptides are known to be immunoregulators.
Fehér
E
E
Department of Anatomy, Semmelweis University of Medicine, Budapest.
Zelles
T
T
Nagy
G
G
D001369:Axons / Q000648:ultrastructure; D001808:Blood Vessels / Q000294:innervation; D006801:Humans; D007150:Immunohistochemistry; D008046:Lip / Q000098:blood supply / Q000294:innervation*; D008214:Lymphocytes / Q000166:cytology; D009410:Nerve Degeneration / Q000473:pathology; D009411:Nerve Endings / Q000648:ultrastructure; D009412:Nerve Fibers / Q000648:ultrastructure*; D009478:Neuropeptide Y / Q000032:analysis; D009479:Neuropeptides / Q000032:analysis* / Q000502:physiology; D009569:Nitric Oxide / Q000032:analysis / Q000502:physiology; D019001:Nitric Oxide Synthase / Q000032:analysis; D012039:Regional Blood Flow / Q000502:physiology; D018987:Salivary Ducts / Q000098:blood supply / Q000294:innervation; D012470:Salivary Glands, Minor / Q000098:blood supply / Q000294:innervation* / Q000378:metabolism; D012859:Sjogren's Syndrome / Q000473:pathology; D013373:Substance P / Q000032:analysis; D014660:Vasoactive Intestinal Peptide / Q000032:analysis; D014665:Vasodilator Agents / Q000494:pharmacology
D009478:Neuropeptide Y; D009479:Neuropeptides; D014665:Vasodilator Agents; D009569:Nitric Oxide; D013373:Substance P; D014660:Vasoactive Intestinal Peptide; D019001:Nitric Oxide Synthase